Thyroid hormone analysis method, analysis system, and detection system
The method of mixing biological samples with solvents at controlled temperatures and using liquid chromatography and mass spectrometry for thyroid hormone analysis in hair samples addresses the inaccuracy of current methods, enabling precise detection and diagnosis of thyroid diseases.
Patent Information
- Application Number
- PCT/JP2024/013552
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-12
- Filing Date
- 2024-04-02
- Publication Date
- 2024-11-21
AI Technical Summary
Current methods for measuring thyroid hormone levels in hair are inaccurate due to the minute amounts present, making it difficult to achieve precise analysis.
A method involving mixing a biological sample with a solvent at controlled temperatures (20°C or less) for up to 12 hours, followed by liquid chromatography and mass spectrometry to separate and analyze thyroid hormone components, such as T3 and T4, using a device equipped with a mass spectrometer for accurate detection.
This approach enables high-accuracy measurement of thyroid hormones, allowing for effective detection and diagnosis of thyroid diseases like Graves' and Hashimoto's by distinguishing hormone levels in healthy and diseased individuals.
Smart Images

Figure JP2024013552_21112024_PF_FP_ABST
Abstract
Description
Thyroid hormone analysis method, analysis system, and detection system
[0001] The present invention relates to a method, an analysis system, and a detection system for thyroid hormones.
[0002] A technique for predicting or diagnosing health conditions or diseases by detecting specific components contained in blood or tissue samples taken from a living body using a mass spectrometer (MS) as indicators of health or disease (biomarkers) is known. Among these biological components, thyroid hormones secreted from the thyroid gland play an important role in regulating metabolism throughout the body and are known to be associated with various diseases such as Graves' disease, Hashimoto's disease, and thyroid cancer. Therefore, it would be advantageous to be able to efficiently analyze thyroid hormones.
[0003] As a method for analyzing thyroid hormone secretion, techniques for measuring thyroid hormone levels from human hair are described in Non-Patent Documents 1 to 3. In the techniques described in Non-Patent Documents 1 to 3, components extracted from human hair are separated by liquid chromatography, and the separated components to be measured are measured using a mass spectrometer.
[0004] N. Grova et. al., Journal of Chromatography A, Volume 1612, 8 February 2020, 460648Wei Gao et al., Psychoneuroendocrinology, Volume 106, August 2019, Pages 129-137Feng-Jiao Peng et al., Eur J Endocrinol, 2022 May 1; 186(5): K9-K15
[0005] Hair, which is used for analysis in the techniques described in Non-Patent Documents 1 to 3, is easy to collect and minimally invasive to collect, making it an excellent biological sample for measuring thyroid hormones. However, the thyroid hormones contained in hair are in trace amounts, making accurate measurement difficult. Therefore, there is a need for the development of a technology for measuring thyroid hormones with high accuracy.
[0006] One aspect of the present invention has been made to solve the above-mentioned problems, and aims to realize a technology for measuring thyroid hormones from hair with high accuracy.
[0007] In order to solve the above-mentioned problems, an analytical method according to one embodiment of the present invention is a method for analyzing thyroid hormones contained in a biological sample, and includes the steps of: mixing the biological sample with a solvent and controlling the temperature at 20°C or higher and 80°C or lower for 0.1 hour or longer and 12 hours or shorter to prepare an extract; subjecting the extract directly to liquid chromatography to separate analyte components in the extract; and subjecting the separated analyte components to mass spectrometry.
[0008] An analytical system according to one embodiment of the present invention is an analytical system for analyzing thyroid hormones contained in a biological sample, and includes an apparatus for separating analytical components in an extract by subjecting the extract directly to liquid chromatography, the extract being prepared by adding a solvent to the biological sample and controlling the temperature to 20°C or higher and 80°C or lower for 0.1 hours or longer and 12 hours or shorter, and a mass spectrometer for performing mass analysis of the separated analytical components.
[0009] A detection system according to one embodiment of the present invention is a detection system for detecting thyroid diseases, and includes an apparatus for separating analytical components in an extract prepared by adding a solvent to the biological sample and controlling the temperature to 20°C or higher and 80°C or lower for 0.1 hours or longer and 12 hours or shorter by subjecting the extract directly to liquid chromatography, and a mass spectrometer for performing mass analysis of the separated analytical components.
[0010] According to one aspect of the present invention, a technique for measuring thyroid hormones with high accuracy can be realized.
[0011] 1 is a block diagram showing the configuration of the main components of an analysis system according to one embodiment of the present invention, and is a diagram showing the results of comparing the analysis results of T3 and T4 extracted from hair between subjects who were not affected by thyroid disease and subjects who were affected by thyroid disease in an example.
[0012] [Analysis Method] An analysis method according to one embodiment of the present invention is a method for analyzing thyroid hormones, which are analytes contained in a biological sample. This analysis method includes the steps of preparing an extract for extracting the analytes from the biological sample, separating the analytes in the extract, and subjecting the separated analytes to mass spectrometry. Examples of thyroid hormones analyzed in this analysis method include triiodothyronine (T3), reverse T3, and thyroxine (T4). Note that the thyroid hormones analyzed in this analysis method may be free thyroid hormones (FT3, FT4, etc.) that are not bound to proteins. Furthermore, in this analysis method, thyroid hormones may be analyzed by analyzing iodine, which constitutes the thyroid hormones.
[0013] <Sample> The biological sample to be analyzed by this analysis method is not particularly limited, but may be a sample that may contain thyroid hormones. The biological sample may be a sample collected or prepared from a human or animal. The biological sample may be selected from the group consisting of hair, nails, skin, organs, tissues, cells, blood, urine, cerebrospinal fluid, feces, and cecal contents, and an example is hair or nails. Hair is also called hair and includes scalp hair and body hair. Hair also includes the hair shaft portion outside the skin and the hair root portion inside the skin, as well as parts involved in hair production, such as the root sheath or hair matrix surrounding the hair root within the hair follicle (or hair follicle).
[0014] (Step of Preparing an Extract) In the step of preparing an extract, a biological sample is mixed with a solvent to prepare an extract. The extract may be prepared by extracting thyroid hormones from a biological sample by a known method such as solvent extraction or solid-phase extraction.
[0015] The solvent added to the biological sample is preferably a solvent that can dissolve thyroid hormones, and examples include methanol, heptane, ethyl acetate, butanol, chloroform, etc. An extract can be prepared by suspending and stirring the biological sample in such a solvent.
[0016] When the biological sample is a solid sample, the amount of the biological sample suspended in the solvent is not particularly limited, but is, for example, 1 mg or more and 10 mg or less.
[0017] The amount of the solvent in which the biological sample is suspended is, for example, 50 μL or more and 200 μL or less, 50 μL or more and 150 μL or less, or 50 μL to 100 μL. When the biological sample is a solid sample, the biological sample may be cut or crushed and suspended in the solvent.
[0018] In the step of preparing an extract, the temperature of the biological sample mixed with the solvent is controlled to 20°C or higher and 80°C or lower. The temperature of the biological sample mixed with the solvent may be controlled to 40°C or higher and 70°C or lower, or 50°C or higher and 60°C or lower. In the step of preparing an extract, the temperature of the biological sample mixed with the solvent is controlled for 0.1 hours or higher and 12 hours or lower. The temperature control time of the biological sample mixed with the solvent may be 1 hour or higher and 8 hours or lower, or 2 hours or higher and 5 hours or lower.
[0019] The extract prepared in the extract preparation step can be directly subjected to the subsequent liquid chromatography without supernatant recovery and drying treatment. In the extract preparation step, a small amount of solvent is used to extract thyroid hormones from a biological sample, and an extract with a high concentration of extracted components can be obtained. Therefore, an extract suitable for analysis can be prepared without concentrating the extracted components by supernatant recovery and drying treatment. The prepared extract may be further mixed with a solvent and distilled water for liquid chromatography to adjust the solvent concentration, and used as a sample for liquid chromatography.
[0020] (Step of Separating Analyte) In the step of separating the analyte, the analyte in the extract is separated by liquid chromatography. In the step of separating the analyte, the extract prepared in the step of preparing the extract is injected into a purification column for liquid chromatography to separate the thyroid hormone, which is the analyte in the extract. In the step of separating the analyte, the extract prepared in the step of preparing the extract is directly subjected to liquid chromatography. One example of the liquid chromatography is reversed-phase liquid chromatography.
[0021] An example of the purification column used in liquid chromatography is a reversed-phase column (C8). The flow rate of the mobile phase in liquid chromatography is, for example, 100 to 400 μL / min. The solvent used in liquid chromatography may be a mixed solvent of water and a solvent. Suitable solvents include, for example, methanol, acetonitrile, and 2-propanol. The amount of extract injected into the purification column is, for example, 50 μL or more and 200 μL or less; 50 μL or more and 150 μL or less; or 50 μL or more and 100 μL or less.
[0022] In the step of separating the analyte, an eluate is obtained by eluting the analyte on the purification column. Then, in the step of performing mass spectrometry described below, the obtained eluate is subjected to mass spectrometry. The amount of solvent used to elute the analyte from the purification column is, for example, 20 μL or more and 150 μL or less; 20 μL or more and 120 μL or less; or 20 μL or more and 100 μL or less.
[0023] In the step of separating the analytes, the eluate from which the analytes are eluted from the purification column can be directly subjected to mass spectrometry, as described below. Because the amount of solvent used to elute the analytes is small, an eluate with a high concentration of the eluted components can be obtained. Therefore, an eluate suitable for mass spectrometry can be prepared without concentrating the analytes by a drying treatment. The obtained eluate can also be dried and then redissolved in a solvent for mass spectrometry.
[0024] (Mass Analysis Step) In the mass analysis step, the analytes separated in the analyte separation step are subjected to mass analysis. In the mass analysis step, the analytes, thyroid hormones, are analyzed using a known mass analyzer such as a triple quadrupole MS. In the mass analysis step, the presence or absence of thyroid hormones in the analytes can be detected. In addition, in the mass analysis step, the amount of thyroid hormones in the analytes can also be measured.
[0025] (Presenting an index of thyroid disease) The present analysis method may further include presenting the measured values of thyroid hormones obtained by mass spectrometry as an index of thyroid disease. In the presenting an index of thyroid disease, a predetermined relationship between the measured values of thyroid hormones and the index of thyroid disease is referenced, and the index of thyroid disease is obtained from the measured values of thyroid hormones obtained by mass spectrometry. The obtained index of thyroid disease is then presented to the user. The presenting an index of thyroid disease may be performed by an information processing device.
[0026] In the step of presenting an indicator of thyroid disease, for example, when a measured value of thyroid hormone is outside a predetermined reference range, an indicator indicating that the thyroid disease level is outside the reference range is presented. Here, for example, the thyroid disease level may indicate a staged likelihood of having a thyroid disease. Examples of thyroid diseases include Graves' disease and Hashimoto's disease.
[0027] The method for presenting the thyroid disease indicators to the user is not particularly limited. For example, the thyroid hormone measurement values and the thyroid disease indicators may be displayed on a computer display, a display of a mobile device such as a smartphone, or the like. Alternatively, the thyroid disease indicators may be presented to the user by providing the user with a medium on which the thyroid hormone measurement values and the thyroid disease indicators are printed.
[0028] [Analysis System] An analysis system according to one aspect of the present invention is an analysis system for analyzing thyroid hormones contained in a biological sample, and includes an apparatus for separating analytes in an extract by liquid chromatography, the extract being prepared by mixing the biological sample with a solvent and controlling the temperature to 20°C or higher and 80°C or lower for 0.1 to 12 hours, and a mass spectrometer for performing mass analysis of the separated analytes. That is, the analysis system according to one aspect of the present invention is one aspect of a system for performing the above-mentioned analysis method according to one aspect of the present invention.
[0029] Fig. 1 is a block diagram showing the main components of an analytical system according to one embodiment of the present invention. As shown in Fig. 1, the analytical system 100 includes a liquid chromatograph (a device that performs separation) 10, a mass spectrometer 20, and a computing device 30. In the analytical system 100, the liquid chromatograph 10 and the mass spectrometer 20 may be independent devices, or may be an integrated device that incorporates the functions of both devices. A known reverse-phase liquid chromatography-mass spectrometer (LC-MS) can be used as an integrated device that incorporates the functions of the liquid chromatograph 10 and the mass spectrometer 20.
[0030] (Liquid Chromatograph) The liquid chromatograph 10 is an apparatus that separates analytes by reversed-phase liquid chromatography. The liquid chromatograph 10 may be a conventionally known liquid chromatograph apparatus, and commercially available apparatuses may be suitably used. The analytes separated by the liquid chromatograph 10 may be a sample prepared in a state suitable for separation in the apparatus, such as an extract obtained by extracting the analytes with a solvent. The liquid chromatograph 10 can separate thyroid hormones, which are analytes in the extract. The eluate containing the analytes separated by the liquid chromatograph 10 is introduced into the mass spectrometer 20.
[0031] (Mass Spectrometer) The mass spectrometer 20 is a device that performs MS analysis of thyroid hormones in a biological sample. The mass spectrometer 20 has an ionization unit 21 that ionizes molecules contained in the eluate obtained in the liquid chromatograph 10, and a detection unit 22 that performs MS analysis of the ionized molecules and detects thyroid hormones in the eluate. The mass spectrometer 20 may be a conventionally known mass spectrometer, and a commercially available device may be suitably used.
[0032] The eluate introduced into the mass spectrometer 20 is first introduced into the ionization unit 21, where molecules in the eluate are ionized. The detection unit 22 separates and detects the molecules ionized in the ionization unit 21 according to their mass-to-charge ratio (m / z ratio). The detection results in the mass spectrometer 20 are output to the calculation device 30.
[0033] (Calculation device) The calculation device 30 generates MS and MS / MS spectra of the thyroid hormones in the eluate based on the detection results output from the mass spectrometer 20, and measures the peak areas to quantify the thyroid hormone molecules in the eluate.
[0034] The calculation device 30 may be, for example, a computer in which software for executing calculations related to MS analysis is installed, and which is equipped with a memory for storing the calculation results, a display for displaying the calculation results, and the like.
[0035] <Example of Implementation by Software> The calculations by the calculation device 30 may be implemented by a logic circuit (hardware) formed on an integrated circuit (IC chip) or the like, or may be implemented by software using a CPU (Central Processing Unit).
[0036] In the latter case, the computing device 30 includes a CPU that executes instructions from a program (software) that implements each function; a ROM (Read Only Memory) or storage device (collectively referred to as a "recording medium") on which the program and various data are stored so that they can be read by a computer (or CPU); and a RAM (Random Access Memory) that expands the program. The object of the present invention is achieved when the computer (or CPU) reads and executes the program from the recording medium. The recording medium may be a "non-transitory tangible medium," such as a tape, disk, card, semiconductor memory, or programmable logic circuit. The program may also be supplied to the computer via any transmission medium capable of transmitting the program (such as a communications network or broadcast waves). The present invention may also be realized in the form of a data signal embedded in a carrier wave, in which the program is embodied by electronic transmission.
[0037] [Detection System and Detection Method] A detection system according to one embodiment of the present invention is a detection system for detecting thyroid disease, and includes an apparatus for separating analytes in an extract by liquid chromatography, which is prepared by adding a solvent to a biological sample and controlling the temperature to 20°C or higher and 80°C or lower for 0.1 hours or longer and 12 hours or shorter, and a mass spectrometer for performing mass analysis of the separated analytes. The detection system according to one embodiment of the present invention is the analysis system according to the above-described embodiment of the present invention, which is used for detecting thyroid disease. The detection system according to one embodiment of the present invention measures thyroid hormone levels in a biological sample and detects thyroid disease based on the measurement results. This detection system can detect whether a subject has a thyroid disease by measuring thyroid hormone levels in a biological sample collected from the subject.
[0038] The present invention also encompasses a method for detecting thyroid disease, which comprises the steps of: mixing a biological sample with a solvent and controlling the temperature at 20°C or higher and 80°C or lower for 0.1 to 12 hours to prepare an extract; separating analyte components in the extract by liquid chromatography; and subjecting the separated analyte components to mass spectrometry. According to this detection method, the presence or absence of a thyroid disease in a subject can be detected by measuring the thyroid hormone level in a biological sample collected from the subject.
[0039] [Additional Note 1] The analytical method according to Aspect 1 of the present invention is a method for analyzing thyroid hormones contained in a biological sample, and includes the steps of: mixing the biological sample with a solvent and controlling the temperature at 20°C or higher and 80°C or lower for 0.1 hour or longer and 12 hours or shorter to prepare an extract; subjecting the extract directly to liquid chromatography to separate analyte components in the extract; and subjecting the separated analyte components to mass spectrometry.
[0040] In the analytical method according to Aspect 2 of the present invention, in the step of separating, the extract is injected into a purification column to separate the analyte components in the extract.
[0041] An analytical method according to a third aspect of the present invention is the same as that of the first or second aspect, wherein in the separating step, an eluate from which the analyte component is eluted on a purification column is obtained, and in the mass spectrometry step, the eluate is subjected to mass spectrometry.
[0042] Aspect 4 of the present invention provides the analytical method of any one of aspects 1 to 3, wherein the biological sample is hair or nail.
[0043] The analytical method according to Aspect 5 of the present invention is the method according to any one of Aspects 1 to 4, further comprising the step of presenting the measured value of the thyroid hormone obtained by the mass spectrometry as an index of a thyroid disease.
[0044] An analytical system according to a sixth aspect of the present invention is an analytical system for analyzing thyroid hormones contained in a biological sample, and includes an apparatus for separating analyte components in an extract by subjecting the extract directly to liquid chromatography, the extract being prepared by adding a solvent to the biological sample and controlling the temperature to 20°C or higher and 80°C or lower for 0.1 to 12 hours, and a mass spectrometer for performing mass analysis of the separated analyte components.
[0045] A detection system according to a seventh aspect of the present invention is a detection system for detecting thyroid diseases, and includes an apparatus for separating analytes in an extract prepared by adding a solvent to a biological sample and controlling the temperature to 20°C or higher and 80°C or lower for 0.1 hours or longer and 12 hours or shorter, by subjecting the extract directly to liquid chromatography, and a mass spectrometer for performing mass analysis of the separated analytes.
[0046] [Additional Note 2] The present invention is not limited to the above-described embodiments, and various modifications are possible within the scope of the claims. Embodiments obtained by appropriately combining the technical means disclosed in different embodiments are also included in the technical scope of the present invention.
[0047] Thyroid hormones in hair were measured as follows: Hair samples were collected from healthy individuals and patients with Graves' disease.
[0048] (Acquisition of biological samples) Hair was cut and collected from the head and scalp of each subject. The cut hair was cut from the root and used. The collected hair was washed and allowed to dry naturally at room temperature before being used for analysis.
[0049] (Preparation of Extract) The hair that had been subjected to the above-described pretreatment was placed in an extraction container, 100 μL of methanol water was added, and extraction was carried out for 4 hours at 60° C. To adjust the methanol concentration, further methanol water was added to prepare an extract.
[0050] (Preparation of eluate) First, the purification column was conditioned. Methanol was applied to the column and then pushed out with air using a syringe. Distilled water was then applied to the column and then pushed out in the same manner.
[0051] 100 μL of the extract prepared as described above was injected into the conditioned column and extruded. Next, the remaining extract was extruded in the same manner. After injecting and extruding hexane for washing, the column was dried by extruding only air.
[0052] Then, 100 μL of methanol was injected, and the liquid pushed out was collected in a new container as the eluate. The collected eluate was dried by blowing nitrogen gas. After drying, methanol was added to the container to redissolve the eluate. Distilled water was then added to the container, and the mixture was mixed well and subjected to mass spectrometry.
[0053] (Analysis) Separation of the extracted sample by reversed-phase liquid chromatography was carried out using an ultra-high performance liquid chromatograph NEXERA X2 (Shimadzu Corporation) as follows. A reversed-phase packing material for ultra-high performance liquid chromatography was used as the packing material for the reversed-phase liquid chromatography column. Gradient elution was carried out using two mobile phases as the mobile phase used in reversed-phase liquid chromatography under acidic conditions. Ionization of the separated molecules was carried out by electrospray ionization (ESI) using a triple quadrupole LCMS-8060 system (Shimadzu Corporation), and MS spectra of T3 and T4 were generated and measured.
[0054] The results of measuring T3 and T4 in hair collected from nine healthy subjects (Healthy Controls) and eight Graves' disease patients (Basedow) are shown in Figure 2. Figure 2 shows the results of comparing the analysis results of T3 and T4 extracted from hair between subjects who were not affected by thyroid disease and subjects who were affected by thyroid disease. In the graph shown in Figure 2, the vertical axis represents the intensity of T4, and the horizontal axis represents the intensity of T3.
[0055] As shown in Figure 2, thyroid hormone levels were measurable in both healthy individuals and Graves' disease patients. Furthermore, as shown in Figure 2, the T3 and T4 levels in hair were significantly different between healthy individuals and Graves' disease patients. Therefore, it was suggested that, for example, by setting reference values for thyroid hormones, such as normal, abnormal, and cautionary levels, and comparing the thyroid hormone levels of subjects with these reference values, they could be used as markers for thyroid disease.
[0056] The present invention can be used in the medical field to predict or diagnose health conditions or diseases.
[0057] REFERENCE SIGNS LIST 10 Liquid chromatograph (analysis device) 20 Mass spectrometer 21 Ionization unit 22 Detection unit 30 Calculation device 100 Analysis system
Claims
1. An analytical method for analyzing thyroid hormones contained in a biological sample, comprising the steps of: mixing the biological sample with a solvent and controlling the temperature at 20°C or higher and 80°C or lower for 0.1 hour or longer and 12 hours or shorter to prepare an extract; subjecting the extract directly to liquid chromatography to separate the analyte components in the extract; and subjecting the separated analyte components to mass spectrometry.
2. The analytical method according to claim 1, wherein in the step of separating, the extract is injected into a purification column to separate the analytical components in the extract.
3. The analytical method according to claim 1 or 2, wherein in the separating step, an eluate from which the analyte component is eluted on a purification column is obtained, and in the mass spectrometry step, the eluate is subjected to mass spectrometry.
4. The analytical method according to claim 1 or 2, wherein the biological sample is hair or nail.
5. The method of claim 1 or 2, further comprising the step of presenting the measured values of thyroid hormone obtained by the mass spectrometry as an index of thyroid disease.
6. An analytical system for analyzing thyroid hormones contained in a biological sample, comprising: a device for separating analytical components in an extract prepared by adding a solvent to the biological sample and controlling the temperature at 20°C or higher and 80°C or lower for a period of 0.1 hour or more and 12 hours or less, by subjecting the extract directly to liquid chromatography; and a mass spectrometer for performing mass analysis of the separated analytical components.
7. A detection system for detecting thyroid diseases, comprising: a device for separating analytical components in an extract prepared by adding a solvent to a biological sample and controlling the temperature at 20°C or higher and 80°C or lower for a period of 0.1 hour or longer and 12 hours or shorter by subjecting the extract directly to liquid chromatography; and a mass spectrometer for performing mass analysis of the separated analytical components.
Citation Information
Patent Citations
Radioactive immune mesuring method of lltriiodotyronine and tyroxin
JP1977003820A
Improved analytical method
JP1977021891A
Favorable Thyroxine and Free Triiodothyronine Analysis by Mass Spectrometry
JP2008534955A
Detection of hormones in hair samples and other biological samples
US20200319213A1
